Been doing some digging into dividend plays lately, and honestly the Dow's got some solid options if you're looking to build passive income streams without chasing moonshots.

Let me break down three names that caught my attention.

First up is Verizon. Look, I get it - the wireless market is basically saturated at this point. You're not going to see explosive growth here. But that's kind of the whole point? The telecom business is predictable, recurring revenue. People aren't cutting their phone service. The forward yield sits around 6.1%, which is honestly tough to find elsewhere without taking on sketchy risk. If you're trying to establish passive cash flow, this is the kind of boring that actually works.

Then there's Merck. This one's interesting because they clearly saw the Keytruda cliff coming - that drug's been carrying about half their sales, and the patent expires in 2028. Instead of panicking, they went on an acquisition spree. We're talking Prometheus Biosciences for $10.8 billion, Verona Pharma for $10 billion, and just recently Cidara Therapeutics for $9.2 billion. These aren't small bets. The company's positioning for $70 billion in new revenue by the mid-2030s. Dividend yield is 2.9% right now, but the real play here is if you've got a long time horizon. You're buying into their next decade of growth.

Finally, Coca-Cola. This is the passive income machine everyone knows about. They've hit 63 consecutive years of dividend increases - about to be 64. The yield is 2.7%, not massive, but the consistency is what matters. People buy Coke. They always have, they always will. It's one of those brands that's basically immune to economic cycles. If you want set-it-and-forget-it passive income with a track record that actually speaks for itself, this is the one.

The common thread here? None of these are going to make you rich quick. But if you're serious about building passive income and you can handle boring, these three Dow names deserve a closer look.